Delivery Order SPE2DE23DA007-SPE2D625F8T1Y
- Not listed
- Cordis US Corp, a Cardinal Health subsidiary specializing in cardiovascular medical devices, has been awarded a delivery order valued at $1,757.07 by the Defense Logistics Agency (DLA) Troop Support Medical, with an ultimate completion date of August 15, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation. Performance will take place at the company's facility in Miami Gardens, Florida. This award...
- Cordis US Corp, a subsidiary of Cardinal Health and a leading manufacturer of cardiovascular medical devices, was awarded a delivery order valued at $1,530.90 by the Defense Logistics Agency Troop Support Medical on August 28, 2025, with an ultimate completion date of September 2, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation and will be performed in Miami Gardens, Florida. The award represents a continuation of Cordis US Corp's ongoing...
- Cordis US Corp, a subsidiary of Cardinal Health and prominent cardiovascular medical device manufacturer, was awarded a delivery order valued at $1,178.10 by the Defense Logistics Agency (DLA) Troop Support Medical on July 10, 2025, with an ultimate completion date of July 14, 2025. The contract utilizes fixed-price pricing with economic price adjustment and carries no set-aside designation. The work will be performed in Miami Gardens, Florida, and represents a continuation of the company's...
- Cordis US Corp, a subsidiary of Cardinal Health and prominent medical device manufacturer specializing in cardiovascular technologies, received a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical on July 29, 2025, valued at $2,347.38. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of July 31, 2025, and will be performed in Miami Gardens, Florida. The award includes no set-aside designation, reflecting Cordis US Corp's...
- This is a $1,275.75 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Cordis US Corp, a leading provider of cardiovascular medical devices and supplies to the U.S. federal government. The contract has an ultimate completion date of May 8, 2025 and is not set aside. Cordis US Corp, a for-profit organization based in Hialeah, Florida, is the prime contractor. This delivery order contract is part of a larger $26.2 million, five-year...
- This delivery order, awarded August 22, 2025, to Cordis US Corp (a Cardinal Health subsidiary) by the Defense Logistics Agency Troop Support Medical, has a ceiling value of $1,126.15 for the supply of an international multipack product (INF TL MULIPACK FR6). The contract is priced on a fixed-price basis with economic price adjustment and carries no set-aside designation. Performance will be executed in Miami Gardens, Florida, with an ultimate completion date of August 26, 2025. Cordis US Corp,...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,677.50 fixed-price delivery order to Cordis US Corp, a leading provider of cardiovascular medical devices and supplies. This order is part of a larger $26.2 million, five-year Indefinite Delivery Vehicle (IDV) contract (SPE2DE23D0019) held by Cordis US Corp to supply cardiovascular and endovascular products to Department of Defense (DoD) research centers, hospitals, and clinics. The specific items ordered are...
- This federal contract award, valued at $1,087.80, was issued by the Defense Logistics Agency Troop Support Medical (DLATSMED-A) to Cordis US Corp, a leading provider of cardiovascular medical devices and supplies to the U.S. government. The contract is a Delivery Order for a variety of cardiovascular products, including catheters, introducers, guide wires, and vascular closure devices. Cordis US Corp holds several significant Indefinite Delivery Vehicles (IDVs) with the DLA Troop Support...
- Cordis US Corp, through its Cordis US Division, has been awarded a $45,052.26 Delivery Order contract (SPE2DE23DA007|SPE2D624F2XSL) by the Defense Logistics Agency Troop Support Medical to provide a variety of cardiovascular medical devices and supplies, including catheters, introducers, guide wires, vascular closure devices, carotid artery stent systems, and iliac artery stents. This contract is not set-aside and is part of a larger $26.2 million, five-year Indefinite Delivery Vehicle (IDV)...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Cordis US Corp, a leading provider of cardiovascular medical devices and supplies, for the supply of various products including stents, catheters, and surgical instruments. The contract has a ceiling value of $1,866.29 and a completion date of August 28, 2024. This order is part of a larger $26.2 million, five-year Indefinite Delivery Vehicle (IDV) contract (SPE2DE23D0019) between Cordis US Corp...
- SPE2DE23DA007Indefinite Delivery Contract
- SPE2DE23DA007-SPE2D625F8T1YDelivery Order
The U.S. Defense Logistics Agency Troop Support Medical awarded a delivery order valued at $1,403.37 to Cordis US Corp for the supply of cardiovascular and endovascular medical devices under the contract designation 4568320639. The award, issued on May 21, 2025, with an ultimate completion date of May 23, 2025, utilizes fixed-price pricing with economic price adjustment terms and carries no set-aside designation. Cordis US Corp, a subsidiary of Cardinal Health based in Hialeah, Florida, will fulfill this order from its place of performance in Miami Gardens, Florida. The delivery order falls under a larger five-year Indefinite Delivery Vehicle valued at $26.2 million spanning March 2023 through March 2028, which serves as the contracting mechanism through which DLA Troop Support Medical procures specialized medical technologies for Department of Defense research centers, hospitals, and clinics. Cordis US Corp maintains a strong market position as a critical supplier of advanced cardiovascular intervention tools, including catheters, stents, guide wires, and related medical devices to federal healthcare institutions. The company's federal contract portfolio, predominantly comprised of delivery orders through the DLA, reflects its specialization in supporting defense and veterans' healthcare sectors. This particular delivery order represents a routine procurement action consistent with the broader IDV framework and Cordis US Corp's established role as a strategic provider of medical technologies essential to DoD healthcare operations and cardiovascular intervention capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 5/21/25 |